Mayo Clinic

Latest statistics and disclosures from Mayo Clinic's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are BSM, ZNTL, SPY, UBX, BSGM, and represent 88.32% of Mayo Clinic's stock portfolio.
  • Added to shares of these 3 stocks: EXAS, BSM, ZNTL.
  • Started 1 new stock positions in EXAS.
  • Reduced shares in these 3 stocks: SPY (-$25M), BSGM, MCRB.
  • Sold out of its positions in MCRB.
  • Mayo Clinic was a net seller of stock by $-25M.
  • Mayo Clinic has $74M in assets under management (AUM), dropping by -29.01%.

Tip: Access up to 7 years of quarterly data

Positions held by Mayo Clinic consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Mayo Clinic

Companies in the Mayo Clinic portfolio as of the September 2020 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Black Stone Minerals Common (BSM) 47.3 $35M 5.7M 6.14
Zentalis Pharmaceuticals Common (ZNTL) 19.5 $15M 443k 32.69
Spdr Etf Common (SPY) 7.5 $5.5M -81% 17k 334.87
Unity Biotechnology Common (UBX) 7.3 $5.4M 1.6M 3.46
Biosig Tech Common (BSGM) 6.7 $5.0M -35% 101k 49.30
Exact Sciences Corp Common (EXAS) 4.5 $3.4M NEW 3.3k 1019.46
Clearpoint Neuro Common (CLPT) 3.5 $2.6M 47k 54.59
Evelo Bioseciences Common (EVLO) 3.4 $2.6M 485k 5.27
Cancer Genetics Common (CGIX) 0.2 $184k 444.00 414.41

Past Filings by Mayo Clinic

SEC 13F filings are viewable for Mayo Clinic going back to 2019